Coronavirus Test Kits Market in Europe 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	162 Pages	TechNavio	September, 2024	INF19286770

Best Price Guarantee
Price	from $2,500
Length	162 Pages
Publisher	TechNavio
Published Date	September, 2024
SKU	INF19286770

Coronavirus Test Kits Market In Europe 2024-2028

The coronavirus test kits market in Europe is forecasted to grow by USD -8 bn during 2023-2028, decelerating at a CAGR of -9.83% during the forecast period. The report on the coronavirus test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, rising focus on preventing the spread of coronavirus, and increasing government funding.

Technavio's coronavirus test kits market in Europe is segmented as below:

By End-user
Government
Non government
By Type
Rapid test kit
RT-PCR
Others
By Geographical Landscape
Europe

This study identifies the advent of SARS-CoV-2 mutation as one of the prime reasons driving the coronavirus test kits market in Europe growth during the next few years. Also, increasing demand for point-of-care diagnostics and rising adoption of rapid diagnostic products will lead to sizable demand in the market.

The report on the coronavirus test kits market in Europe covers the following areas:

Coronavirus test kits market in Europe sizing
Coronavirus test kits market in Europe forecast
Coronavirus test kits market in Europe industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in Europe vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., BioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc, Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, Perkin Elmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED. Also, the coronavirus test kits market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Regional - Market size and forecast 2023-2028 ($ million); Chart on Europe: Year-over-year growth 2023-2028 (%); Data Table on Regional - Market size and forecast 2023-2028 ($ million)
4 Additional Value/Volume Data: 4.1 Coronavirus test kits market in Europe 2020 - 2022 ($ million); Market Size (value) - Data Table on Coronavirus test kits market in Europe 2020 - 2022 ($ million); 4.2 Coronavirus test kits market in Europe by End-user 2020 - 2022 ($ million); Market Size (value) - Data Table on Coronavirus test kits market in Europe by End-user 2020 - 2022 ($ million); 4.3 Coronavirus test kits market in Europe by Type 2020 - 2022 ($ million); Market Size (value) - Data Table on Coronavirus test kits market in Europe by Type 2020 - 2022 ($ million); 4.4 Coronavirus test kits market in Europe by country 2020 - 2022 ($ million); Market Size (value) - Data Table on Coronavirus test kits market in Europe by Country 2020 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Government - Market size and forecast 2023-2028; Chart on Government - Market size and forecast 2023-2028 ($ million); Data Table on Government - Market size and forecast 2023-2028 ($ million); Chart on Government - Year-over-year growth 2023-2028 (%); Data Table on Government - Year-over-year growth 2023-2028 (%); 6.4 Non government - Market size and forecast 2023-2028; Chart on Non government - Market size and forecast 2023-2028 ($ million); Data Table on Non government - Market size and forecast 2023-2028 ($ million); Chart on Non government - Year-over-year growth 2023-2028 (%); Data Table on Non government - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Rapid test kit - Market size and forecast 2023-2028; Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million); Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million); Chart on Rapid test kit - Year-over-year growth 2023-2028 (%); Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%); 7.4 RT-PCR - Market size and forecast 2023-2028; Chart on RT-PCR - Market size and forecast 2023-2028 ($ million); Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million); Chart on RT-PCR - Year-over-year growth 2023-2028 (%); Data Table on RT-PCR - Year-over-year growth 2023-2028 (%); 7.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape - 2023-2028 (%); Data Table on Market share By Geographical Landscape - 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 Russia - Market size and forecast 2023-2028; Chart on Russia - Market size and forecast 2023-2028 ($ million); Data Table on Russia - Market size and forecast 2023-2028 ($ million); Chart on Russia - Year-over-year growth 2023-2028 (%); Data Table on Russia - Year-over-year growth 2023-2028 (%); 9.4 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.5 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.6 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.7 Rest of Europe - Market size and forecast 2023-2028; Chart on Rest of Europe - Market size and forecast 2023-2028 ($ million); Data Table on Rest of Europe - Market size and forecast 2023-2028 ($ million); Chart on Rest of Europe - Year-over-year growth 2023-2028 (%); Data Table on Rest of Europe - Year-over-year growth 2023-2028 (%); 9.8 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 3D Biomedicine Science and Technology Co. Ltd.; 3D Biomedicine Science and Technology Co. Ltd. - Overview; 3D Biomedicine Science and Technology Co. Ltd. - Product / Service; 3D Biomedicine Science and Technology Co. Ltd. - Key offerings; 12.4 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.5 altona Diagnostics GmbH; altona Diagnostics GmbH - Overview; altona Diagnostics GmbH - Product / Service; altona Diagnostics GmbH - Key offerings; 12.6 BGI Genomics Co. Ltd.; BGI Genomics Co. Ltd. - Overview; BGI Genomics Co. Ltd. - Product / Service; BGI Genomics Co. Ltd. - Key offerings; 12.7 Bio Rad Laboratories Inc.; Bio Rad Laboratories Inc. - Overview; Bio Rad Laboratories Inc. - Business segments; Bio Rad Laboratories Inc. - Key news; Bio Rad Laboratories Inc. - Key offerings; Bio Rad Laboratories Inc. - Segment focus; 12.8 BioMerieux SA; BioMerieux SA - Overview; BioMerieux SA - Business segments; BioMerieux SA - Key news; BioMerieux SA - Key offerings; BioMerieux SA - Segment focus; 12.9 BIOSYNEX SA; BIOSYNEX SA - Overview; BIOSYNEX SA - Product / Service; BIOSYNEX SA - Key offerings; 12.10 Bruker Corp.; Bruker Corp. - Overview; Bruker Corp. - Business segments; Bruker Corp. - Key news; Bruker Corp. - Key offerings; Bruker Corp. - Segment focus; 12.11 Co Diagnostics Inc; Co Diagnostics Inc - Overview; Co Diagnostics Inc - Product / Service; Co Diagnostics Inc - Key offerings; 12.12 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; 12.13 Edinburgh Genetics Ltd.; Edinburgh Genetics Ltd. - Overview; Edinburgh Genetics Ltd. - Product / Service; Edinburgh Genetics Ltd. - Key offerings; 12.14 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.15 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; 12.17 ZEKMED; ZEKMED - Overview; ZEKMED - Product / Service; ZEKMED - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Europe: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Regional - Market size and forecast 2023-2028 ($ million); Exhibits20: Market Size (value) - Data Table on Coronavirus test kits market in Europe 2020 - 2022 ($ million); Exhibits21: Market Size (value) - Data Table on Coronavirus test kits market in Europe by End-user 2020 - 2022 ($ million); Exhibits22: Market Size (value) - Data Table on Coronavirus test kits market in Europe by Type 2020 - 2022 ($ million); Exhibits23: Market Size (value) - Data Table on Coronavirus test kits market in Europe by Country 2020 - 2022 ($ million); Exhibits24: Five forces analysis - Comparison between 2023 and 2028; Exhibits25: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits27: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits28: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits29: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits30: Chart on Market condition - Five forces 2023 and 2028; Exhibits31: Chart on End-user - Market share 2023-2028 (%); Exhibits32: Data Table on End-user - Market share 2023-2028 (%); Exhibits33: Chart on Comparison by End-user; Exhibits34: Data Table on Comparison by End-user; Exhibits35: Chart on Government - Market size and forecast 2023-2028 ($ million); Exhibits36: Data Table on Government - Market size and forecast 2023-2028 ($ million); Exhibits37: Chart on Government - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Government - Year-over-year growth 2023-2028 (%); Exhibits39: Chart on Non government - Market size and forecast 2023-2028 ($ million); Exhibits40: Data Table on Non government - Market size and forecast 2023-2028 ($ million); Exhibits41: Chart on Non government - Year-over-year growth 2023-2028 (%); Exhibits42: Data Table on Non government - Year-over-year growth 2023-2028 (%); Exhibits43: Market opportunity by End-user ($ million); Exhibits44: Data Table on Market opportunity by End-user ($ million); Exhibits45: Chart on Type - Market share 2023-2028 (%); Exhibits46: Data Table on Type - Market share 2023-2028 (%); Exhibits47: Chart on Comparison by Type; Exhibits48: Data Table on Comparison by Type; Exhibits49: Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Rapid test kit - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on RT-PCR - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on RT-PCR - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on RT-PCR - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits61: Market opportunity by Type ($ million); Exhibits62: Data Table on Market opportunity by Type ($ million); Exhibits63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits64: Chart on Market share By Geographical Landscape - 2023-2028 (%); Exhibits65: Data Table on Market share By Geographical Landscape - 2023-2028 (%); Exhibits66: Chart on Geographic comparison; Exhibits67: Data Table on Geographic comparison; Exhibits68: Chart on Russia - Market size and forecast 2023-2028 ($ million); Exhibits69: Data Table on Russia - Market size and forecast 2023-2028 ($ million); Exhibits70: Chart on Russia - Year-over-year growth 2023-2028 (%); Exhibits71: Data Table on Russia - Year-over-year growth 2023-2028 (%); Exhibits72: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits73: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits74: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits75: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits76: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits77: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits78: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits79: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits80: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits81: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits82: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits83: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits84: Chart on Rest of Europe - Market size and forecast 2023-2028 ($ million); Exhibits85: Data Table on Rest of Europe - Market size and forecast 2023-2028 ($ million); Exhibits86: Chart on Rest of Europe - Year-over-year growth 2023-2028 (%); Exhibits87: Data Table on Rest of Europe - Year-over-year growth 2023-2028 (%); Exhibits88: Market opportunity By Geographical Landscape ($ million); Exhibits89: Data Table on Market opportunity By Geographical Landscape ($ million); Exhibits90: Impact of drivers and challenges in 2023 and 2028; Exhibits91: Overview on criticality of inputs and factors of differentiation; Exhibits92: Overview on factors of disruption; Exhibits93: Impact of key risks on business; Exhibits94: Companies covered; Exhibits95: Matrix on companies position and classification; Exhibits96: 3D Biomedicine Science and Technology Co. Ltd. - Overview; Exhibits97: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service; Exhibits98: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings; Exhibits99: Abbott Laboratories - Overview; Exhibits100: Abbott Laboratories - Business segments; Exhibits101: Abbott Laboratories - Key news; Exhibits102: Abbott Laboratories - Key offerings; Exhibits103: Abbott Laboratories - Segment focus; Exhibits104: altona Diagnostics GmbH - Overview; Exhibits105: altona Diagnostics GmbH - Product / Service; Exhibits106: altona Diagnostics GmbH - Key offerings; Exhibits107: BGI Genomics Co. Ltd. - Overview; Exhibits108: BGI Genomics Co. Ltd. - Product / Service; Exhibits109: BGI Genomics Co. Ltd. - Key offerings; Exhibits110: Bio Rad Laboratories Inc. - Overview; Exhibits111: Bio Rad Laboratories Inc. - Business segments; Exhibits112: Bio Rad Laboratories Inc. - Key news; Exhibits113: Bio Rad Laboratories Inc. - Key offerings; Exhibits114: Bio Rad Laboratories Inc. - Segment focus; Exhibits115: BioMerieux SA - Overview; Exhibits116: BioMerieux SA - Business segments; Exhibits117: BioMerieux SA - Key news; Exhibits118: BioMerieux SA - Key offerings; Exhibits119: BioMerieux SA - Segment focus; Exhibits120: BIOSYNEX SA - Overview; Exhibits121: BIOSYNEX SA - Product / Service; Exhibits122: BIOSYNEX SA - Key offerings; Exhibits123: Bruker Corp. - Overview; Exhibits124: Bruker Corp. - Business segments; Exhibits125: Bruker Corp. - Key news; Exhibits126: Bruker Corp. - Key offerings; Exhibits127: Bruker Corp. - Segment focus; Exhibits128: Co Diagnostics Inc - Overview; Exhibits129: Co Diagnostics Inc - Product / Service; Exhibits130: Co Diagnostics Inc - Key offerings; Exhibits131: Danaher Corp. - Overview; Exhibits132: Danaher Corp. - Business segments; Exhibits133: Danaher Corp. - Key news; Exhibits134: Danaher Corp. - Key offerings; Exhibits135: Danaher Corp. - Segment focus; Exhibits136: Edinburgh Genetics Ltd. - Overview; Exhibits137: Edinburgh Genetics Ltd. - Product / Service; Exhibits138: Edinburgh Genetics Ltd. - Key offerings; Exhibits139: F. Hoffmann La Roche Ltd. - Overview; Exhibits140: F. Hoffmann La Roche Ltd. - Business segments; Exhibits141: F. Hoffmann La Roche Ltd. - Key news; Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits144: QIAGEN NV - Overview; Exhibits145: QIAGEN NV - Product / Service; Exhibits146: QIAGEN NV - Key news; Exhibits147: QIAGEN NV - Key offerings; Exhibits148: Thermo Fisher Scientific Inc. - Overview; Exhibits149: Thermo Fisher Scientific Inc. - Business segments; Exhibits150: Thermo Fisher Scientific Inc. - Key news; Exhibits151: Thermo Fisher Scientific Inc. - Key offerings; Exhibits152: Thermo Fisher Scientific Inc. - Segment focus; Exhibits153: ZEKMED - Overview; Exhibits154: ZEKMED - Product / Service; Exhibits155: ZEKMED - Key offerings; Exhibits156: Inclusions checklist; Exhibits157: Exclusions checklist; Exhibits158: Currency conversion rates for US$; Exhibits159: Research methodology; Exhibits160: Information sources; Exhibits161: Data validation; Exhibits162: Validation techniques employed for market sizing; Exhibits163: Data synthesis; Exhibits164: 360 degree market analysis; Exhibits165: List of abbreviations